{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T01:01:51Z","timestamp":1794704511513,"version":"4.9.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","award":["020700"],"award-info":[{"award-number":["020700"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","award":["020700"],"award-info":[{"award-number":["020700"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K02NS080915, UL1 TR000040"],"award-info":[{"award-number":["K02NS080915, UL1 TR000040"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015569","name":"Consortium canadien en neurod\u00e9g\u00e9n\u00e9rescence associ\u00e9e au vieillissement","doi-asserted-by":"publisher","award":["049-14"],"award-info":[{"award-number":["049-14"]}],"id":[{"id":"10.13039\/100015569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010785","name":"Canada First Research Excellence Fund","doi-asserted-by":"publisher","award":["247908"],"award-info":[{"award-number":["247908"]}],"id":[{"id":"10.13039\/501100010785","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    One of the most common genetic risk factors for Parkinson\u2019s disease (PD) is variants in\n                    <jats:italic>GBA1<\/jats:italic>\n                    , which encodes the lysosomal enzyme glucocerebrosidase (GCase). GCase deficiency has been associated with an increased PD risk, but not all individuals with low GCase activity are carriers of\n                    <jats:italic>GBA1<\/jats:italic>\n                    mutations, suggesting other factors may be acting as modifiers. We aimed to discover common variants associated with GCase activity, as well as replicate previously reported associations, by performing a genome-wide association study using two independent cohorts: a Columbia University cohort consisting of 697 PD cases and 347 controls and the Parkinson\u2019s Progression Markers Initiative (PPMI) cohort consisting of 357 PD cases and 163 controls. As expected,\n                    <jats:italic>GBA1<\/jats:italic>\n                    variants have the strongest association with decreased activity, led by N370S (beta\u2009=\u2009\u2009\u2212\u20094.36, se\u2009=\u20090.32,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20095.05e\u2009\u2212\u200943). We also identify a novel association in the\n                    <jats:italic>GAA<\/jats:italic>\n                    locus (encoding for acid alpha-glucosidase, beta\u2009=\u2009\u2009\u2212\u20090.96, se\u2009=\u20090.17,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20095.23e\u2009\u2212\u200909) that may be the result of an interaction between GCase and acid alpha-glucosidase based on various interaction analyses. Lastly, we show that several PD-risk loci are potentially associated with GCase activity. Further research will be needed to replicate and validate our findings and to uncover the functional connection between acid alpha-glucosidase and GCase.\n                  <\/jats:p>","DOI":"10.1007\/s12035-025-04996-1","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T05:55:53Z","timestamp":1745906153000},"page":"11560-11571","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Genome-Wide Association Study of Glucocerebrosidase Activity Modifiers"],"prefix":"10.1007","volume":"62","author":[{"given":"Emma N.","family":"Somerville","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne","family":"Krohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin","family":"Senkevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamil","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farnaz","family":"Asayesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Ruskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Spiegelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley","family":"Fahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Waters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Pablo","family":"Sardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy N.","family":"Alcalay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziv","family":"Gan-Or","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"issue":"6","key":"4996_CR1","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong MJ, Okun MS (2020) Diagnosis and treatment of parkinson disease: a review. JAMA 323(6):548\u2013560. https:\/\/doi.org\/10.1001\/jama.2019.22360","journal-title":"JAMA"},{"issue":"8","key":"4996_CR2","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s11910-018-0860-4","volume":"18","author":"Z Gan-Or","year":"2018","unstructured":"Gan-Or Z, Liong C, Alcalay RN (2018) GBA-associated Parkinson\u2019s disease and other synucleinopathies. Curr Neurol Neurosci Rep 18(8):44. https:\/\/doi.org\/10.1007\/s11910-018-0860-4","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"5","key":"4996_CR3","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/humu.20676","volume":"29","author":"KS Hruska","year":"2008","unstructured":"Hruska KS, LaMarca ME, Scott CR, Sidransky E (2008) Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA). Hum Mutat 29(5):567\u2013583. https:\/\/doi.org\/10.1002\/humu.20676","journal-title":"Hum Mutat"},{"issue":"Pt 9","key":"4996_CR4","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1093\/brain\/awv179","volume":"138","author":"RN Alcalay","year":"2015","unstructured":"Alcalay RN, Levy OA, Waters CC, Fahn S, Ford B, Kuo SH, Mazzoni P, Pauciulo MW et al (2015) Glucocerebrosidase activity in Parkinson\u2019s disease with and without GBA mutations. Brain 138(Pt 9):2648\u20132658. https:\/\/doi.org\/10.1093\/brain\/awv179","journal-title":"Brain"},{"issue":"2","key":"4996_CR5","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1007\/s12035-018-1090-0","volume":"56","author":"TE Moors","year":"2019","unstructured":"Moors TE, Paciotti S, Ingrassia A, Quadri M, Breedveld G, Tasegian A, Chiasserini D, Eusebi P et al (2019) Characterization of brain lysosomal activities in gba-related and sporadic Parkinson\u2019s disease and dementia with lewy bodies. Mol Neurobiol 56(2):1344\u20131355. https:\/\/doi.org\/10.1007\/s12035-018-1090-0","journal-title":"Mol Neurobiol"},{"issue":"1","key":"4996_CR6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/ana.25629","volume":"87","author":"L Krohn","year":"2020","unstructured":"Krohn L, Ozturk TN, Vanderperre B, Ouled Amar Bencheikh B, Ruskey JA, Laurent SB, Spiegelman D, Postuma RB et al (2020) Genetic, structural, and functional evidence link TMEM175 to synucleinopathies. Ann Neurol 87(1):139\u2013153. https:\/\/doi.org\/10.1002\/ana.25629","journal-title":"Ann Neurol"},{"issue":"9","key":"4996_CR7","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1073\/pnas.1616332114","volume":"114","author":"S Jinn","year":"2017","unstructured":"Jinn S, Drolet RE, Cramer PE, Wong AH, Toolan DM, Gretzula CA, Voleti B, Vassileva G et al (2017) TMEM175 deficiency impairs lysosomal and mitochondrial function and increases alpha-synuclein aggregation. Proc Natl Acad Sci U S A 114(9):2389\u20132394. https:\/\/doi.org\/10.1073\/pnas.1616332114","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"4996_CR8","doi-asserted-by":"publisher","first-page":"5570","DOI":"10.1038\/s41467-019-13413-w","volume":"10","author":"D Ysselstein","year":"2019","unstructured":"Ysselstein D, Nguyen M, Young TJ, Severino A, Schwake M, Merchant K, Krainc D (2019) LRRK2 kinase activity regulates lysosomal glucocerebrosidase in neurons derived from Parkinson\u2019s disease patients. Nat Commun 10(1):5570. https:\/\/doi.org\/10.1038\/s41467-019-13413-w","journal-title":"Nat Commun"},{"issue":"10","key":"4996_CR9","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1002\/acn3.51164","volume":"7","author":"RN Alcalay","year":"2020","unstructured":"Alcalay RN, Wolf P, Chiang MSR, Helesicova K, Zhang XK, Merchant K, Hutten SJ, Scherzer C et al (2020) Longitudinal measurements of glucocerebrosidase activity in Parkinson\u2019s patients. Ann Clin Transl Neurol 7(10):1816\u20131830. https:\/\/doi.org\/10.1002\/acn3.51164","journal-title":"Ann Clin Transl Neurol"},{"key":"4996_CR10","doi-asserted-by":"publisher","first-page":"142141","DOI":"10.1016\/j.neurobiolaging.2021.02.018","volume":"103","author":"YL Sosero","year":"2021","unstructured":"Sosero YL, Yu E, Krohn L, Rudakou U, Mufti K, Ruskey JA, Asayesh F, Laurent SB et al (2021) LRRK2 p. M1646T is associated with glucocerebrosidase activity and with Parkinson\u2019s disease. Neurobiol Aging 103:142141\u2013142145. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2021.02.018","journal-title":"Neurobiol Aging"},{"issue":"1","key":"4996_CR11","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s10897-013-9618-y","volume":"23","author":"K Sakanaka","year":"2014","unstructured":"Sakanaka K, Waters CH, Levy OA, Louis ED, Chung WK, Marder KS, Alcalay RN (2014) Knowledge of and interest in genetic results among Parkinson disease patients and caregivers. J Genet Couns 23(1):114\u2013120. https:\/\/doi.org\/10.1007\/s10897-013-9618-y","journal-title":"J Genet Couns"},{"issue":"1\u20132","key":"4996_CR12","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.ymgme.2011.07.014","volume":"104","author":"AJ Reuser","year":"2011","unstructured":"Reuser AJ, Verheijen FW, Bali D, van Diggelen OP, Germain DP, Hwu WL, Lukacs Z, Muhl A et al (2011) The use of dried blood spot samples in the diagnosis of lysosomal storage disorders\u2013current status and perspectives. Mol Genet Metab 104(1\u20132):144\u2013148. https:\/\/doi.org\/10.1016\/j.ymgme.2011.07.014","journal-title":"Mol Genet Metab"},{"issue":"5","key":"4996_CR13","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1093\/brain\/awac413","volume":"146","author":"K Senkevich","year":"2023","unstructured":"Senkevich K, Zorca CE, Dworkind A, Rudakou U, Somerville E, Yu E, Ermolaev A, Nikanorova D et al (2023) GALC variants affect galactosylceramidase enzymatic activity and risk of Parkinson\u2019s disease. Brain 146(5):1859\u20131872. https:\/\/doi.org\/10.1093\/brain\/awac413","journal-title":"Brain"},{"issue":"3","key":"4996_CR14","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P et al (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81(3):559\u2013575. https:\/\/doi.org\/10.1086\/519795","journal-title":"Am J Hum Genet"},{"issue":"10","key":"4996_CR15","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/ng.3656","volume":"48","author":"S Das","year":"2016","unstructured":"Das S, Forer L, Schonherr S, Sidore C, Locke AE, Kwong A, Vrieze SI, Chew EY et al (2016) Next-generation genotype imputation service and methods. Nat Genet 48(10):1284\u20131287. https:\/\/doi.org\/10.1038\/ng.3656","journal-title":"Nat Genet"},{"issue":"1","key":"4996_CR16","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41531-022-00354-3","volume":"8","author":"M Kedariti","year":"2022","unstructured":"Kedariti M, Frattini E, Baden P, Cogo S, Civiero L, Ziviani E, Zilio G, Bertoli F et al (2022) LRRK2 kinase activity regulates GCase level and enzymatic activity differently depending on cell type in Parkinson\u2019s disease. NPJ Parkinsons Dis 8(1):92. https:\/\/doi.org\/10.1038\/s41531-022-00354-3","journal-title":"NPJ Parkinsons Dis"},{"key":"4996_CR17","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.nbd.2018.01.012","volume":"112","author":"RN Alcalay","year":"2018","unstructured":"Alcalay RN, Wolf P, Levy OA, Kang UJ, Waters C, Fahn S, Ford B, Kuo SH et al (2018) Alpha galactosidase A activity in Parkinson\u2019s disease. Neurobiol Dis 112:85\u201390. https:\/\/doi.org\/10.1016\/j.nbd.2018.01.012","journal-title":"Neurobiol Dis"},{"key":"4996_CR18","doi-asserted-by":"publisher","unstructured":"Yang J, Ferreira T, Morris AP, Medland SE, Genetic Investigation of ATC, Replication DIG, Meta-analysis C, Madden PA, Heath AC, Martin NG, Montgomery GW, Weedon MN, Loos RJ, Frayling TM, McCarthy MI, Hirschhorn JN, Goddard ME, Visscher PM (2012) Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits. Nat Genet 44 (4):369\u2013375, S361\u2013363. https:\/\/doi.org\/10.1038\/ng.2213","DOI":"10.1038\/ng.2213"},{"key":"4996_CR19","unstructured":"R Development Core Team (2023) R: A language and environment for statistcal computing. 4.3.1 edn. R Foundation for Statistical Computing, Vienna, Austria"},{"issue":"18","key":"4996_CR20","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1093\/bioinformatics\/btq419","volume":"26","author":"RJ Pruim","year":"2010","unstructured":"Pruim RJ, Welch RP, Sanna S, Teslovich TM, Chines PS, Gliedt TP, Boehnke M, Abecasis GR et al (2010) LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics 26(18):2336\u20132337. https:\/\/doi.org\/10.1093\/bioinformatics\/btq419","journal-title":"Bioinformatics"},{"issue":"6","key":"4996_CR21","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1002\/mds.27659","volume":"34","author":"C Blauwendraat","year":"2019","unstructured":"Blauwendraat C, Heilbron K, Vallerga CL, Bandres-Ciga S, von Coelln R, Pihlstrom L, Simon-Sanchez J, Schulte C et al (2019) Parkinson\u2019s disease age at onset genome-wide association study: Defining heritability, genetic loci, and alpha-synuclein mechanisms. Mov Disord 34(6):866\u2013875. https:\/\/doi.org\/10.1002\/mds.27659","journal-title":"Mov Disord"},{"issue":"12","key":"4996_CR22","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1002\/mds.27845","volume":"34","author":"H Iwaki","year":"2019","unstructured":"Iwaki H, Blauwendraat C, Leonard HL, Kim JJ, Liu G, Maple-Grodem J, Corvol JC, Pihlstrom L et al (2019) Genomewide association study of Parkinson\u2019s disease clinical biomarkers in 12 longitudinal patients\u2019 cohorts. Mov Disord 34(12):1839\u20131850. https:\/\/doi.org\/10.1002\/mds.27845","journal-title":"Mov Disord"},{"issue":"12","key":"4996_CR23","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","volume":"18","author":"MA Nalls","year":"2019","unstructured":"Nalls MA, Blauwendraat C, Vallerga CL, Heilbron K, Bandres-Ciga S, Chang D, Tan M, Kia DA et al (2019) Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies. Lancet Neurol 18(12):1091\u20131102. https:\/\/doi.org\/10.1016\/S1474-4422(19)30320-5","journal-title":"Lancet Neurol"},{"issue":"2","key":"4996_CR24","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/mds.28342","volume":"36","author":"MMX Tan","year":"2021","unstructured":"Tan MMX, Lawton MA, Jabbari E, Reynolds RH, Iwaki H, Blauwendraat C, Kanavou S, Pollard MI et al (2021) Genome-wide association studies of cognitive and motor progression in Parkinson\u2019s disease. Mov Disord 36(2):424\u2013433. https:\/\/doi.org\/10.1002\/mds.28342","journal-title":"Mov Disord"},{"issue":"11","key":"4996_CR25","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s11940-022-00736-1","volume":"24","author":"D Stevens","year":"2022","unstructured":"Stevens D, Milani-Nejad S, Mozaffar T (2022) Pompe disease: a clinical, diagnostic, and therapeutic overview. Curr Treat Options Neurol 24(11):573\u2013588. https:\/\/doi.org\/10.1007\/s11940-022-00736-1","journal-title":"Curr Treat Options Neurol"},{"issue":"12","key":"4996_CR26","doi-asserted-by":"publisher","first-page":"167932","DOI":"10.1016\/j.jmb.2022.167932","volume":"435","author":"R Machtel","year":"2023","unstructured":"Machtel R, Boros FA, Dobert JP, Arnold P, Zunke F (2023) From lysosomal storage disorders to Parkinson\u2019s disease - challenges and opportunities. J Mol Biol 435(12):167932. https:\/\/doi.org\/10.1016\/j.jmb.2022.167932","journal-title":"J Mol Biol"},{"issue":"4","key":"4996_CR27","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1002\/mds.27642","volume":"34","author":"RN Alcalay","year":"2019","unstructured":"Alcalay RN, Mallett V, Vanderperre B, Tavassoly O, Dauvilliers Y, Wu RYJ, Ruskey JA, Leblond CS et al (2019) SMPD1 mutations, activity, and alpha-synuclein accumulation in Parkinson\u2019s disease. Mov Disord 34(4):526\u2013535. https:\/\/doi.org\/10.1002\/mds.27642","journal-title":"Mov Disord"},{"issue":"17","key":"4996_CR28","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1212\/WNL.0b013e31828f180e","volume":"80","author":"Z Gan-Or","year":"2013","unstructured":"Gan-Or Z, Ozelius LJ, Bar-Shira A, Saunders-Pullman R, Mirelman A, Kornreich R, Gana-Weisz M, Raymond D et al (2013) The p.L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for Parkinson disease. Neurology 80(17):1606\u20131610. https:\/\/doi.org\/10.1212\/WNL.0b013e31828f180e","journal-title":"Neurology"},{"key":"4996_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2021.108822","volume":"202","author":"K Senkevich","year":"2022","unstructured":"Senkevich K, Rudakou U, Gan-Or Z (2022) New therapeutic approaches to Parkinson\u2019s disease targeting GBA, LRRK2 and Parkin. Neuropharmacology 202:108822. https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108822","journal-title":"Neuropharmacology"},{"key":"4996_CR30","doi-asserted-by":"publisher","unstructured":"Robak LA, Jansen IE, van Rooij J, Uitterlinden AG, Kraaij R, Jankovic J, International Parkinson\u2019s Disease Genomics C, Heutink P, Shulman JM (2017) Excessive burden of lysosomal storage disorder gene variants in Parkinson\u2019s disease. Brain 140 (12):3191-3203. https:\/\/doi.org\/10.1093\/brain\/awx285","DOI":"10.1093\/brain\/awx285"},{"issue":"11","key":"4996_CR31","doi-asserted-by":"publisher","first-page":"4622","DOI":"10.1093\/brain\/awad214","volume":"146","author":"MB Makarious","year":"2023","unstructured":"Makarious MB, Lake J, Pitz V, Fu AY, Guidubaldi JL, Solsberg CW, Bandres-Ciga S, Leonard HL et al (2023) Large-scale rare variant burden testing in Parkinson\u2019s disease. Brain 146(11):4622\u20134632. https:\/\/doi.org\/10.1093\/brain\/awad214","journal-title":"Brain"},{"key":"4996_CR32","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.neurobiolaging.2021.08.008","volume":"109","author":"HX Pan","year":"2022","unstructured":"Pan HX, Wang YG, Zhao YW, Zeng Q, Wang Z, Fang ZH, Zhang Y, Zhou X et al (2022) Evaluating the role of ARSA in Chinese patients with Parkinson\u2019s disease. Neurobiol Aging 109:269\u2013272. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2021.08.008","journal-title":"Neurobiol Aging"},{"issue":"7","key":"4996_CR33","doi-asserted-by":"publisher","first-page":"5025","DOI":"10.1007\/s12035-015-9426-5","volume":"53","author":"S Deng","year":"2016","unstructured":"Deng S, Deng X, Song Z, Xiu X, Guo Y, Xiao J, Deng H (2016) Systematic genetic analysis of the SMPD1 gene in Chinese patients with Parkinson\u2019s disease. Mol Neurobiol 53(7):5025\u20135029. https:\/\/doi.org\/10.1007\/s12035-015-9426-5","journal-title":"Mol Neurobiol"},{"key":"4996_CR34","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.parkreldis.2016.10.014","volume":"34","author":"CY Mao","year":"2017","unstructured":"Mao CY, Yang J, Wang H, Zhang SY, Yang ZH, Luo HY, Li F, Shi M et al (2017) SMPD1 variants in Chinese Han patients with sporadic Parkinson\u2019s disease. Parkinsonism Relat Disord 34:59\u201361. https:\/\/doi.org\/10.1016\/j.parkreldis.2016.10.014","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"4996_CR35","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1002\/mds.28987","volume":"37","author":"L Straniero","year":"2022","unstructured":"Straniero L, Rimoldi V, Monfrini E, Bonvegna S, Melistaccio G, Lake J, Sold\u00e0 G, Aureli M et al (2022) Role of lysosomal gene variants in modulating associated Parkinson\u2019s disease risk. Movement Disord 37(6):1202\u20131210. https:\/\/doi.org\/10.1002\/mds.28987","journal-title":"Movement Disord"},{"key":"4996_CR36","doi-asserted-by":"publisher","first-page":"749109","DOI":"10.3389\/fnagi.2021.749109","volume":"13","author":"YW Zhao","year":"2021","unstructured":"Zhao YW, Pan HX, Liu ZH, Wang YG, Zeng Q, Fang ZH, Luo TF, Xu K et al (2021) The association between lysosomal storage disorder genes and Parkinson\u2019s disease: a large cohort study in Chinese mainland population. Front Aging Neurosci 13:749109. https:\/\/doi.org\/10.3389\/fnagi.2021.749109","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"4996_CR37","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1038\/s41467-017-01263-3","volume":"8","author":"V Roig-Zamboni","year":"2017","unstructured":"Roig-Zamboni V, Cobucci-Ponzano B, Iacono R, Ferrara MC, Germany S, Bourne Y, Parenti G, Moracci M et al (2017) Structure of human lysosomal acid alpha-glucosidase-a guide for the treatment of Pompe disease. Nat Commun 8(1):1111. https:\/\/doi.org\/10.1038\/s41467-017-01263-3","journal-title":"Nat Commun"},{"issue":"17","key":"4996_CR38","doi-asserted-by":"publisher","first-page":"9241","DOI":"10.3390\/ijms22179241","volume":"22","author":"D Arango","year":"2021","unstructured":"Arango D, Bittar A, Esmeral NP, Ocasion C, Munoz-Camargo C, Cruz JC, Reyes LH, Bloch NI (2021) Understanding the potential of genome editing in Parkinson\u2019s disease. Int J Mol Sci 22(17):9241. https:\/\/doi.org\/10.3390\/ijms22179241","journal-title":"Int J Mol Sci"},{"issue":"4","key":"4996_CR39","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ymgme.2017.11.001","volume":"122","author":"N Tayebi","year":"2017","unstructured":"Tayebi N, Parisiadou L, Berhe B, Gonzalez AN, Serra-Vinardell J, Tamargo RJ, Maniwang E, Sorrentino Z et al (2017) Glucocerebrosidase haploinsufficiency in A53T alpha-synuclein mice impacts disease onset and course. Mol Genet Metab 122(4):198\u2013208. https:\/\/doi.org\/10.1016\/j.ymgme.2017.11.001","journal-title":"Mol Genet Metab"},{"key":"4996_CR40","doi-asserted-by":"publisher","first-page":"106534","DOI":"10.1016\/j.bpc.2020.106534","volume":"273","author":"SS Munoz","year":"2021","unstructured":"Munoz SS, Petersen D, Marlet FR, Kucukkose E, Galvagnion C (2021) The interplay between glucocerebrosidase, alpha-synuclein and lipids in human models of Parkinson\u2019s disease. Biophys Chem 273:106534. https:\/\/doi.org\/10.1016\/j.bpc.2020.106534","journal-title":"Biophys Chem"},{"issue":"Pt 12","key":"4996_CR41","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1093\/brain\/awu291","volume":"137","author":"I Fishbein","year":"2014","unstructured":"Fishbein I, Kuo YM, Giasson BI, Nussbaum RL (2014) Augmentation of phenotype in a transgenic Parkinson mouse heterozygous for a Gaucher mutation. Brain 137(Pt 12):3235\u20133247. https:\/\/doi.org\/10.1093\/brain\/awu291","journal-title":"Brain"},{"issue":"4","key":"4996_CR42","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1006\/bbrc.2000.4253","volume":"280","author":"T Nakamura","year":"2001","unstructured":"Nakamura T, Yamashita H, Takahashi T, Nakamura S (2001) Activated Fyn phosphorylates alpha-synuclein at tyrosine residue 125. Biochem Biophys Res Commun 280(4):1085\u20131092. https:\/\/doi.org\/10.1006\/bbrc.2000.4253","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04996-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-04996-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04996-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T04:06:43Z","timestamp":1755662803000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-04996-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":42,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["4996"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-04996-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.03.27.586821","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-4425669\/v1","asserted-by":"object"}]},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"assertion":[{"value":"15 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have read and consented to publish this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"Z.G.O received consultancy fees from Lysosomal Therapeutics Inc. (LTI), Idorsia, Prevail Therapeutics, Ono Therapeutics, Denali, Handl Therapeutics, Neuron23, Bial Biotech, Bial, UCB, Capsida, Vanqua bio, Congruence Therapeutics, Takeda, Jazz Guidepoint, Lighthouse and Deerfield.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"Informed consent forms were signed by all participants prior to entering their respective studies, and the study protocol was approved by the institutional review boards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}}]}}